Enliven Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Enliven Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $-0.48 | $-0.50 | 4.00 % |
Jun 2024 | 2024-08-13 | $-0.41 | $-0.55 | 25.4 % |
Mar 2024 | 2024-05-14 | $-0.54 | $-0.57 | 5.26 % |
Dec 2023 | 2024-03-14 | $-0.47 | $-0.54 | 13.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Enliven Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.
Enliven Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-0.48, which beat the estimate of $-0.50.
Enliven Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.